High-Frequency Topical Cyclosporine 0.05% in the Treatment of Severe Dry Eye Refractory to Twice-Daily Regimen

Cornea - United States
doi 10.1097/ico.0b013e3181a16472
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cyclosporine, Prednisone, and High-Dose Immunoglobulin Treatment of Angioimmunoblastic T-Cell Lymphoma Refractory to Prior CHOP or CHOP-like Regimen

Chinese Journal of Cancer
2011English

Efficacy and Safety of Autologous Serum Eye Drops in Treatment of Severe Dry Eye

IOSR Journal of Dental and Medical Sciences
2014English

Vitamin D Supplementation for Patients With Dry Eye Syndrome Refractory to Conventional Treatment

Scientific Reports
Multidisciplinary
2016English

Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye Upon Treatment With Cyclosporine Eye Drops

Current Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma

Respiratory Research
PulmonaryRespiratory Medicine
2011English

Cyclosporine - An Eye Opener in Severe Cutaneous Adverse Drug Reactions

IP Indian Journal of Clinical and Experimental Dermatology
2018English

Adverse Effect Profile of Topical Ocular Administration of Fingolimod for Treatment of Dry Eye Disease

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Real-World Treatment Patterns of Cyclosporine Ophthalmic Emulsion and Lifitegrast Ophthalmic Solution Among Patients With Dry Eye

Clinical Ophthalmology
Ophthalmology
2019English

Autologous Serum in Treatment of Dry Eye

Medicinski Pregled
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy